These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1520 related items for PubMed ID: 31722708

  • 1. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention.
    Luo E, Wang D, Yan G, Qiao Y, Liu B, Hou J, Tang C.
    Cardiovasc Diabetol; 2019 Nov 13; 18(1):150. PubMed ID: 31722708
    [Abstract] [Full Text] [Related]

  • 2. Triglyceride glucose index combined with plaque characteristics as a novel biomarker for cardiovascular outcomes after percutaneous coronary intervention in ST-elevated myocardial infarction patients: an intravascular optical coherence tomography study.
    Zhao X, Wang Y, Chen R, Li J, Zhou J, Liu C, Zhou P, Sheng Z, Chen Y, Song L, Zhao H, Yan H.
    Cardiovasc Diabetol; 2021 Jun 28; 20(1):131. PubMed ID: 34183007
    [Abstract] [Full Text] [Related]

  • 3. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome.
    Ma X, Dong L, Shao Q, Cheng Y, Lv S, Sun Y, Shen H, Wang Z, Zhou Y, Liu X.
    Cardiovasc Diabetol; 2020 Mar 10; 19(1):31. PubMed ID: 32156279
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Impact of triglyceride-glucose index on intracoronary thrombus burden in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.
    Köktürk U, Önalan O, Somuncu MU, Akgül Ö, Uygur B, Püşüroğlu H.
    Nutr Metab Cardiovasc Dis; 2024 Apr 10; 34(4):860-867. PubMed ID: 38336545
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China.
    Hu C, Zhang J, Liu J, Liu Y, Gao A, Zhu Y, Zhao Y.
    Cardiovasc Diabetol; 2020 Jul 23; 19(1):116. PubMed ID: 32703284
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Triglyceride-glucose body mass index predicts prognosis in patients with ST-elevation myocardial infarction.
    Liu M, Pan J, Meng K, Wang Y, Sun X, Ma L, Yu X.
    Sci Rep; 2024 Jan 10; 14(1):976. PubMed ID: 38200157
    [Abstract] [Full Text] [Related]

  • 13. Triglyceride-Glucose Index as a Surrogate Marker of Insulin Resistance for Predicting Cardiovascular Outcomes in Nondiabetic Patients with Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Zhao Q, Zhang TY, Cheng YJ, Ma Y, Xu YK, Yang JQ, Zhou YJ.
    J Atheroscler Thromb; 2021 Nov 01; 28(11):1175-1194. PubMed ID: 33191314
    [Abstract] [Full Text] [Related]

  • 14. Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents.
    Zhu Y, Liu K, Chen M, Liu Y, Gao A, Hu C, Li H, Zhu H, Han H, Zhang J, Zhao Y.
    Cardiovasc Diabetol; 2021 Jul 08; 20(1):137. PubMed ID: 34238294
    [Abstract] [Full Text] [Related]

  • 15. Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China.
    Zhao Q, Zhang TY, Cheng YJ, Ma Y, Xu YK, Yang JQ, Zhou YJ.
    Cardiovasc Diabetol; 2020 Jul 08; 19(1):108. PubMed ID: 32641127
    [Abstract] [Full Text] [Related]

  • 16. Triglyceride-glucose index as a predictor of cardiac adverse events in acute coronary syndrome patients undergoing percutaneous coronary intervention: role of diabetes.
    Khalaji A, Behnoush AH, Pasebani Y, Rafati A, Mahmoodi T, Arzhangzadeh A, Shamshiri Khamene S, MohammadKhawajah I, Mehrani M, Vasheghani-Farahani A, Masoudkabir F, Najafi K, Askari MK, Harrison A, Nelson JR, Hosseini K, Hernandez AV.
    BMC Cardiovasc Disord; 2024 Sep 27; 24(1):514. PubMed ID: 39333881
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 76.